Skip to search formSkip to main contentSkip to account menu

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

Known as: HBV Nucleoside Analog Reverse Transcriptase Inhibitor (HBV-NRTI), HBV NRTI, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BIOCHEMISTRY Correction for “Probing the structural and molecular basis of nucleotide selectivity by human mitochondrial DNA… 
2015
2015
Significance Nucleoside analog reverse transcriptase inhibitors (NRTIs) are the cornerstones of treatment for fighting HIV… 
2012
2012
Nucleoside reverse transcriptase inhibitors (NRTIs) remain a critical component of therapy for HIV-infected patients. The drugs… 
2012
2012
In two 48‐week studies in naïve subjects, dolutegravir with NRTI of choice has shown non‐inferiority to raltegravir and, with ABC… 
2008
2008
While it is known that selection for specific HIV-1 drug resistance-associated mutations (DRM) occurs following ART failure, the… 
2007
2007
Background Intracellular nucleoside reverse transcriptase inhibitor triphosphate (NRTI-TP) concentrations are crucial in… 
2007
2007
We evaluated the efficacy of tenofovir (TDF) – and didanosine (ddI)-containing backbones in HIV-infected experienced subjects. We… 
Review
2006
Review
2006
Nucleoside reverse transcriptase inhibitors (NRTI) are essential components of highly active antiretroviral treatment (HAART… 
Review
2003